SCHEMBL1420977

SCHEMBL1420977

C[C@@H]1C[C@@](C)(c2cccc(-c3cncnc3)c2)SC(NC(=O)OC(C)(C)C)=N1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.37
BACE1 P56817 8/20 0.36
CYP17A1 P05093 1/20 0.35
KCNH2 Q12809 3/20 0.35
BRD4 O60885 2/20 0.34
CREBBP Q92793 2/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33
CCR2 P41597 1/20 0.33
ABL1 P00519 3/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1421083 0.91 SYK (0.37) SYKBACE1CYP17A1KCNH2BRD4
SCHEMBL1420884 0.89 SYK (0.37) SYKBACE1CYP17A1KCNH2BRD4
SCHEMBL1420673 0.86 BACE1 (0.39) BACE1CYP17A1ABL1
SCHEMBL1420882 0.84 HCRTR1 (0.36) BACE1BRD4CREBBPHCRTR1HCRTR2
SCHEMBL3171758 0.80 BACE1 (0.40) SYKBACE1CYP17A1KCNH2BRD4
SCHEMBL4310210 0.79 BACE1 (0.38) BACE1KCNH2CCR2ABL1CNR1
SCHEMBL1421136 0.77 ABL1 (0.36) BACE1CYP17A1ABL1
SCHEMBL1424309 0.77 ABL1 (0.36) BACE1CYP17A1ABL1
SCHEMBL1421023 0.77 BACE1 (0.38) BACE1CYP17A1HCRTR1HCRTR2CCR2
SCHEMBL1421032 0.76 BACE1 (0.38) SYKBACE1CYP17A1KCNH2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297120-A1 AMINODIHYDROTHIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Eli Lilly & Company (US) 2011-03-23 EP disclosed
WO-2009134617-A1 AMINODIHYDROTHIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 2009-11-05 WO disclosed